Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
Line 22: Line 22:
 
** [[Media:COPD_Profile_v1.0.doc|COPD Profile v1.0]]
 
** [[Media:COPD_Profile_v1.0.doc|COPD Profile v1.0]]
  
 +
*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]
  
  
Line 28: Line 29:
  
 
* Phantom project
 
* Phantom project
 
 
==Slide Presentations==
 
 
*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]
 
  
  

Revision as of 16:50, 5 January 2010

This Wiki is for collaborative creation of QIBA's Chronic Obstructive Pulmonary Disease (COPD) and Asthma Committee materials and ongoing activities.


Mission: Reduce and characterize bias and variance across manufacturers, versions, and sites in support of quantitative CT lung densitometry and morphology.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.


Project Snapshot

Profiling Activities

Write Profile documents to which equipment and sites can conform to accomplish Quantification goals.


Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project


Meetings / Call Summaries


Working Documents


Reference Documents